Population-based analysis of invasive fungal infections, Emerg Infect Dis, vol.20, pp.1163-1169, 2001. ,
Epidemiology of visceral mycoses in autopsy cases in Japan: the data from 1989 to 2009 in the Annual of Pathological Autopsy Cases in Japan, Med Mycol, vol.51, pp.522-526, 2013. ,
Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study, Mycoses, vol.56, pp.638-645, 2013. ,
Improvement of fungal disease identification and management: combined health systems and public health approaches, Lancet Infect Dis, vol.17, pp.412-419, 2017. ,
, Antifungal drug maps | Gaffi -Global Action Fund for Fungal Infections, 2018.
Risk stratification for invasive aspergillosis in immunocompromised patients: risk stratification for invasive aspergillosis, Ann N Y Acad Sci, vol.1272, pp.23-30, 2012. ,
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia, N Engl J Med, vol.356, pp.348-359, 2007. ,
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease, N Engl J Med, vol.356, pp.335-347, 2007. ,
Changing epidemiology of invasive mold infections in patients receiving azole prophylaxis, Clin Infect Dis, vol.64, pp.1619-1621, 2017. ,
, Epidemiological trends in invasive aspergillosis in France: the SAIF network, vol.17, pp.1882-1889, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00680990
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study, Haematologica, vol.102, pp.108-111, 2017. ,
Aspergillus in the lower respiratory tract of immunocompetent critically ill patients, J Infect, vol.69, pp.284-292, 2014. ,
Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes, Crit Care, vol.19, p.7, 2015. ,
Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients, Crit Care, vol.10, p.31, 2006. ,
Invasive aspergillosis in patients with severe alcoholic hepatitis, J Hepatol, vol.60, pp.267-274, 2014. ,
Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series, BMC Gastroenterol, vol.7, issue.2, 2007. ,
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET), Clin Infect Dis, vol.50, pp.1101-1111, 2010. ,
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome, Clin Microbiol Infect, vol.16, pp.870-877, 2010. ,
Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis, Mycoses, vol.46, pp.19-23, 2003. ,
Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis, Transplantation, vol.97, pp.351-357, 2014. ,
Epidemiology and clinical characteristics of invasive mould infections: a multicenter, retrospective analysis in five Asian countries, Med Mycol, vol.56, pp.186-196, 2018. ,
Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature, Medicine, vol.91, pp.328-336, 2012. ,
Invasive aspergillosis associated with severe influenza infections, Open Forum Infect Dis, vol.3, p.171, 2016. ,
Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients, Clin Infect Dis, vol.53, pp.16-19, 2011. ,
Influenza-associated aspergillosis in critically ill patients, Am J Respir Crit Care Med, vol.196, pp.524-527, 2017. ,
Pulmonary aspergillosis in the acquired immunodeficiency syndrome, N Engl J Med, vol.324, pp.654-662, 1991. ,
Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS, Am J Med, vol.95, pp.177-187, 1993. ,
Relevance of EORTC criteria for the diagnosis of invasive aspergillosis in HIV-infected patients, and survival trends over a 20-year period in France, Clin Infect Dis, vol.61, pp.1273-1280, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01225497
Common severe infections in chronic granulomatous disease, Clin Infect Dis, vol.60, pp.1176-1183, 2015. ,
Chronic granulomatous disease in patients reaching adulthood: a nationwide study in France, Clin Infect Dis, vol.64, pp.767-775, 2017. ,
Human neutrophils use different mechanisms to kill Aspergillus fumigatus conidia and hyphae: evidence from phagocyte defects, J Immunol, vol.196, pp.1272-1283, 2016. ,
Aspergillus nidulans infection in chronic granulomatous disease, Medicine, vol.77, pp.345-354, 1998. ,
Deep dermatophytosis and inherited CARD9 deficiency, N Engl J Med, vol.369, pp.1704-1714, 2013. ,
ExtrapulmonaryAspergillusinfection in patients with CARD9 deficiency, JCI Insight, vol.1, p.89890, 2016. ,
Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects, Blood, vol.124, pp.590-597, 2014. ,
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey, Medicine, vol.91, pp.1-19, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00717018
Invasive fungal disease in autosomal-dominant hyper-IgE syndrome, J Allergy Clin Immunol, vol.125, pp.1389-1390, 2010. ,
Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome, J Allergy Clin Immunol, vol.104, pp.1265-1272, 1999. ,
Causes of death in hyper-IgE syndrome, J Allergy Clin Immunol, vol.119, pp.1234-1240, 2007. ,
Aspergillus spp. infections in STAT3 deficient patients: a nationwide study in France, 7th Advances Against Aspergillosis, 2016. ,
Genetic susceptibility to fungal infections in humans, Curr Fungal Infect Rep, vol.6, pp.11-22, 2012. ,
Primary immunodeficiencies underlying fungal infections, Curr Opin Pediatr, vol.25, pp.736-747, 2013. ,
Drug-specific risk of nontuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry, Ann Rheum Dis, vol.70, pp.616-623, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00875446
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib, Blood, vol.131, pp.1955-1959, 2018. ,
Serious infections in patients receiving ibrutinib for treatment of lymphoid malignancies, Clin Infect Dis, vol.67, pp.687-692, 2018. ,
Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis, Leuk Lymphoma, vol.58, pp.2981-2982, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01851918
The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma, Clin Infect Dis, vol.63, pp.1490-1493, 2016. ,
Opportunistic infections in patients treated with immunotherapy for cancer, J Immunother Cancer, vol.2, p.19, 2014. ,
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign, Clin Infect Dis, vol.44, pp.373-379, 2007. ,
Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia, J Clin Oncol, vol.19, pp.253-259, 2001. ,
The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?, Clin Infect Dis, vol.58, pp.672-678, 2014. ,
Reversed halo sign in invasive pulmonary fungal kinfections, Clin Infect Dis, vol.46, pp.1733-1737, 2008. ,
The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies, Blood, vol.119, pp.1831-1837, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00818508
Magnetic resonance imaging of cerebral aspergillosis: imaging and pathological correlations, PLOS ONE, vol.11, p.152475, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01377871
Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases, Clin Infect Dis, vol.40, pp.1141-1147, 2005. ,
Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome, J Infect, vol.68, pp.478-493, 2014. ,
Aspergillus arthritis: analysis of clinical manifestations, diagnosis, and treatment of 31 reported cases, Med Mycol, vol.55, pp.246-254, 2017. ,
Aspergillus pericarditis with tamponade: report of a successfully treated case and review, Clin Infect Dis, vol.26, pp.451-460, 1998. ,
Multimodality diagnosis approach of cardiac aspergillosis, Echocardiogr Mt Kisco N, vol.33, pp.663-665, 2016. ,
Aspergillus endocarditis in the era of new antifungals: major role for antigen detection, J Infect, vol.67, pp.85-88, 2013. ,
The role of 18 F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropenia, Leuk Res, vol.37, pp.1057-1062, 2013. ,
The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections, Med Mycol, vol.46, pp.23-29, 2008. ,
Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections, Clin Microbiol Infect, vol.17, pp.409-417, 2011. ,
Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients, Clin Microbiol Infect, vol.7, pp.54-61, 2001. ,
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery, J Clin Oncol, vol.15, pp.139-147, 1997. ,
Practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clin Infect Dis, vol.63, pp.1-60, 2016. ,
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline, Clin Microbiol Infect, vol.24, pp.1-38, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01953645
Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial, Clin Infect Dis, vol.48, pp.1042-1051, 2009. ,
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial, Lancet Infect Dis, vol.13, pp.519-528, 2013. ,
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation, Blood, vol.116, pp.5111-5118, 2010. ,
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation, Br J Haematol, vol.155, pp.318-327, 2011. ,
Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus, Emerg Infect Dis, vol.21, pp.1041-1044, 2015. ,
The value of computed tomographyguided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients, Clin Infect Dis, vol.45, pp.101-104, 2007. ,
Cutaneous invasive aspergillosis: retrospective multicenter study of the French invasive-aspergillosis registry and literature review, Medicine, vol.94, p.1018, 2015. ,
Fungal skin and soft tissue infections, Curr Opin Infect Dis, vol.29, pp.124-130, 2016. ,
Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases, Clin Infect Dis, vol.49, pp.1688-1693, 2009. ,
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases, Lancet Infect Dis, vol.15, pp.461-474, 2015. ,
Histopathologic diagnosis of fungal infections in the 21st century, Clin Microbiol Rev, vol.24, pp.247-280, 2011. ,
Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive aspergillosis enhances diagnostic capabilities, J Clin Microbiol, vol.51, pp.4178-4185, 2013. ,
Validation and clinical application of molecular methods for the identification of molds in tissue, Clin Infect Dis, vol.42, pp.51-56, 2006. ,
Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis, Clin Infect Dis, vol.42, pp.1417-1727, 2006. ,
Galactomannan detection for invasive aspergillosis in immunocompromized patients, Cochrane Database Syst Rev, p.7394, 2015. ,
Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay, Eur J Clin Microbiol Infect Dis, vol.27, pp.245-251, 2008. ,
, Accuracy of BAL Galactomannan in diagnosing invasive aspergillosis, vol.138, pp.817-824, 2010.
Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study, Clin Infect Dis, vol.41, pp.1242-1250, 2005. ,
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients, Bone Marrow Transplant, vol.47, pp.846-854, 2012. ,
Serum galactomannanbased early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis, Clin Infect Dis, vol.59, pp.1696-1702, 2014. ,
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay, Clin Infect Dis, vol.40, pp.1762-1769, 2005. ,
Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study, Bone Marrow Transplant, vol.52, pp.326-329, 2017. ,
, Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3), vol.54, pp.633-643, 2012.
Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing, Clin Infect Dis, vol.61, pp.1293-1303, 2015. ,
Prospective evaluation of serum ?-glucan testing in patients with probable or proven fungal diseases, Open Forum Infect Dis, vol.3, p.128, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01518025
Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people, Cochrane Database Syst Rev ,
Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance, J Clin Microbiol, vol.46, pp.3772-3777, 2008. ,
Circulating Aspergillus fumigatus DNA is quantitatively correlated to galactomannan in serum, Front Microbiol, vol.8, p.2040, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01851829
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis, N Engl J Med, vol.347, pp.408-415, 2002. ,
Clinical implications of azole resistance in Aspergillus fumigatus, Emerg Infect Dis, vol.17, pp.1846-1854, 2007. ,
Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid, J Clin Microbiol, vol.53, pp.868-874, 2015. ,
Analytical and clinical evaluation of the pathonostics AsperGenius Assay for detection of invasive aspergillosis and resistance to azole antifungal drugs during testing of serum samples, J Clin Microbiol, vol.53, pp.2115-2121, 2015. ,
Analytical and clinical evaluation of the pathonostics AsperGenius Assay for detection of invasive aspergillosis and resistance to azole antifungal drugs directly from plasma samples, J Clin Microbiol, vol.55, pp.2356-2366, 2017. ,
Molecular diagnosis of invasive aspergillosis and detection of azole resistance by a newly commercialized PCR kit, J Clin Microbiol, vol.55, pp.3210-3218, 2017. ,
Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial, Clin Infect Dis, vol.60, pp.405-414, 2015. ,
Use and limits of (1-3)-?-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis, J Clin Microbiol, vol.52, pp.2328-2333, 2014. ,
Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateralflow device for diagnosis of invasive aspergillosis, J Clin Microbiol, vol.51, pp.1510-1516, 2013. ,
Novel cutting-edge metabolite-based diagnostic tools for aspergillosis, PLoS Pathog, vol.13, p.1006486, 2017. ,
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clin Infect Dis, vol.46, pp.1813-1821, 2008. ,